✦ LIBER ✦

P-532 Survival rates in non-selected consecutive patients with advanced and metastatic non-small cell lung cancer (NSCLC): A retrospective analysis from a lung cancer center

✍ Scribed by Martens, U.; Bludau, P.; Kaiser, P.; Schulte Mönting, J.; Digel, W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multi-center study with paclitaxel (P)/c

✍ Glorieux, P; Ortmanns, P; Marien, S; Degives, R; Degraeve, D; Potvin, M; Grauwel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Multimodality therapy improves survival

✍ Harshita R. Paripati; Nina J. Karlin; Steven E. Schild; Sujay A. Vora; Amylou C. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 436 KB

PCN58 A COST UTILITY ANALYSIS OF ERLOTIN

✍ PA Bradbury; R Jang; P Isogai; R Ng; N Mittmann; W Evans; FA Shepherd; NB Leighl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

P-559 A phase II study of oxallplatln an

✍ Raez, L.; Santos, E.; Rocha-Lima, C.; Roman, E.; Kumar, P.; Farfan, N.; Decesare 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

CLC036 POSTER Relationship between age t

✍ Heras, P.; Hatzopoulos, A.; Kritikos, K.; Georgopoulou, A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

P-26 Phase II trial with RFS 2000 (9NC)

✍ Baka, Sofia; Lorigan, Paul; Danson, Sarah; White, Alison; Joyce, Patrick; Thatch 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 192 KB